Sequential intravesical immunochemotherapy for stages Ta And T1 transitional cell carcinoma of the bladder: an update
African Journal of Urology. 2003; 9 (3): 117-122
in English
| IMEMR
| ID: emr-205555
ABSTRACT
Objectives:
To present an update of our experience with sequential immuno-chemotherapy using bacillus Calmette-Guerin [BCG] and epirubicin in superficial bladder tumors. In addition, the question of whether to start with BCG or epirubicin is answered
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Language:
English
Journal:
African J. Urol.
Year:
2003
Similar
MEDLINE
...
LILACS
LIS